News
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing ...
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clini ...
4d
TipRanks on MSNVivani Medical Secures $10M Through Share Purchase Agreement
Vivani Medical ( ($VANI) ) has shared an update. On August 11, 2025, Vivani Medical entered into a Share Purchase Agreement to sell 7,936,507 ...
4d
TipRanks on MSNVivani Medical Reports Q2 2025 Results and $10M Financing
Vivani Medical, Inc. ( (VANI) ) has released its Q2 earnings. Here is a breakdown of the information Vivani Medical, Inc. presented to its investors.Elevate Your Investing Strategy: Take advantage of ...
Vivani Medical announced that it brought in $10 million in equity financing as it progresses its drug delivery technology.
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clini ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results